MustGrow Biologics Financials
| MGRO Stock | 0.80 0.04 4.76% |
MustGrow |
Understanding current and past MustGrow Biologics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of MustGrow Biologics' financial statements are interrelated, with each one affecting the others. For example, an increase in MustGrow Biologics' assets may result in an increase in income on the income statement.
The data published in MustGrow Biologics' official financial statements typically reflect MustGrow Biologics' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving MustGrow Biologics' quantitative information. For example, before you start analyzing numbers published by MustGrow accountants, it's essential to understand MustGrow Biologics' liquidity, profitability, and earnings quality within the context of the Chemicals space in which it operates.
Please note, the imprecision that can be found in MustGrow Biologics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MustGrow Biologics Corp. Check MustGrow Biologics' Beneish M Score to see the likelihood of MustGrow Biologics' management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Canada Stock View All |
| Exchange | TSX Venture Exchange |
| Business Address | 1005 201 1st |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Website | mustgrow.ca |
| Phone | 306 668 2652 |
You should never invest in MustGrow Biologics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of MustGrow Stock, because this is throwing your money away. Analyzing the key information contained in MustGrow Biologics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
MustGrow Biologics Key Financial Ratios
There are many critical financial ratios that MustGrow Biologics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that MustGrow Biologics Corp reports annually and quarterly.| Return On Equity | -0.15 | |||
| Return On Asset | -0.0151 | |||
| Beta | 1.67 |
MustGrow Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining MustGrow Biologics's current stock value. Our valuation model uses many indicators to compare MustGrow Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MustGrow Biologics competition to find correlations between indicators driving MustGrow Biologics's intrinsic value. More Info.MustGrow Biologics Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MustGrow Biologics' earnings, one of the primary drivers of an investment's value.MustGrow Biologics Corp Systematic Risk
MustGrow Biologics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MustGrow Biologics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on MustGrow Biologics Corp correlated with the market. If Beta is less than 0 MustGrow Biologics generally moves in the opposite direction as compared to the market. If MustGrow Biologics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MustGrow Biologics Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MustGrow Biologics is generally in the same direction as the market. If Beta > 1 MustGrow Biologics moves generally in the same direction as, but more than the movement of the benchmark.
MustGrow Biologics June 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of MustGrow Biologics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MustGrow Biologics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of MustGrow Biologics Corp based on widely used predictive technical indicators. In general, we focus on analyzing MustGrow Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MustGrow Biologics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 17.52 | |||
| Value At Risk | (5.00) | |||
| Potential Upside | 5.0 |
Additional Tools for MustGrow Stock Analysis
When running MustGrow Biologics' price analysis, check to measure MustGrow Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MustGrow Biologics is operating at the current time. Most of MustGrow Biologics' value examination focuses on studying past and present price action to predict the probability of MustGrow Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MustGrow Biologics' price. Additionally, you may evaluate how the addition of MustGrow Biologics to your portfolios can decrease your overall portfolio volatility.